Scientific Advances in Lung Cancer 2015.

Détails

ID Serval
serval:BIB_02E8A7A685FB
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Scientific Advances in Lung Cancer 2015.
Périodique
Journal of thoracic oncology
Auteur(s)
Tsao A.S., Scagliotti G.V., Bunn P.A., Carbone D.P., Warren G.W., Bai C., de Koning H.J., Yousaf-Khan A.U., McWilliams A., Tsao M.S., Adusumilli P.S., Rami-Porta R., Asamura H., Van Schil P.E., Darling G.E., Ramalingam S.S., Gomez D.R., Rosenzweig K.E., Zimmermann S., Peters S., Ignatius Ou S.H., Reungwetwattana T., Jänne P.A., Mok T.S., Wakelee H.A., Pirker R., Mazières J., Brahmer J.R., Zhou Y., Herbst R.S., Papadimitrakopoulou V.A., Redman M.W., Wynes M.W., Gandara D.R., Kelly R.J., Hirsch F.R., Pass H.I.
ISSN
1556-1380 (Electronic)
ISSN-L
1556-0864
Statut éditorial
Publié
Date de publication
05/2016
Peer-reviewed
Oui
Volume
11
Numéro
5
Pages
613-638
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Lung cancer continues to be a major global health problem; the disease is diagnosed in more than 1.6 million new patients each year. However, significant progress is underway in both the prevention and treatment of lung cancer. Lung cancer therapy has now emerged as a "role model" for precision cancer medicine, with several important therapeutic breakthroughs occurring during 2015. These advances have occurred primarily in the immunotherapy field and in treatments directed against tumors harboring specific oncogenic drivers. Our knowledge about molecular mechanisms for oncogene-driven tumors and about resistance to targeted therapies has increased quickly over the past year. As a result, several regulatory approvals of new agents that significantly improve survival and quality of life for patients with lung cancer who have advanced disease have occurred. The International Association for the Study of Lung Cancer has gathered experts in different areas of lung cancer research and management to summarize the most significant scientific advancements related to prevention and therapy of lung cancer during the past year.

Mots-clé
Humans, Immunotherapy, Lung Neoplasms/diagnosis, Lung Neoplasms/therapy, Precision Medicine, Quality of Life, Adjuvant chemotherapy, Biomarkers, Cancer prevention, Gene mutations, Lung cancer, Master protocols, Pathology, Radiotherapy, Screening, Smoking cessation, Staging, Surgery, Targeted therapy, Value of therapy
Pubmed
Web of science
Open Access
Oui
Création de la notice
10/04/2016 14:22
Dernière modification de la notice
02/09/2019 18:03
Données d'usage